Philip Loury, University of California San Diego
The treatment of the Human Immunodeficiency Virus strain HIV-1 requires close monitoring of patient viral load in order to verify that treatment is successfully inhibiting replication of the retrovirus. The impact of HIV drug resistance (DR) following the initiation of first-line antiretroviral therapy (ART) is an emerging issue of critical importance to the success of HIV treatment in developing countries. Hospitals in developing nations cannot afford such testing or lack personnel and equipment for proper sample preparation and analysis. In order to confront this challenge, the Engineering World Health chapter at UCSD has launched a project to design a cost-effective point-of-care solution to screen HIV patients for ART drug resistance, thus enabling hospitals and clinics in the developing world to better diagnose and appropriately treat their patients.
Accepting Nominations for 2017-2019 International Board of Directors
Monday, 27 Mar 2017 14.03
Data Integrity: Do You GAMP?
Friday, 24 Mar 2017 13.03
Nominate Your Facility for 2018 Facility of the Year Awards
Thursday, 23 Mar 2017 18.03